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Abstract
Nitric oxide (NO) is an important modulator of immune, endocrine and neuronal functions; however, measuring
physiological levels of NO in cell cultures is generally difficult because of the lack of suitable methodologies. We have selected
three cell lines from different origins: the neuroblastoma-derived Neuro2A (N2A), the cholinergic SN56 and the non-
neuronal COS-1. We first demonstrated the presence of NADPH-diaphoretic activity, a potential marker of the NO-
synthesizing (NOS) enzyme. By immunocytochemistry, using specific antibodies for each NOS subtype, we observed that
subtype I was present in all cell lines and that subtype II was present in COS-1 and N2A cell lines. The presence of these NOS
subtypes was further verified by Western blot analysis. Control cells treated with DAF-2 DA exhibited significant fluorescent
levels corresponding to basal NO production. The subcellular distribution of the synthesizing enzyme was consistent with the
NO-fluorescence signal ; whereas, fixation affected the subcellular pattern of NO fluorescence signal. Addition of NOS
inhibitors or NO scavengers to the incubation medium reduced the intensity of the NO fluorescence signal in a
concentration-dependent manner. Conversely, increasing concentrations of a NO donor, or incident light, increased the
fluorescence intensity. Our observation of NO production and distribution using the DAF-2 method has a direct impact on
studies using these cell lines. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Nitric oxide synthase (NOS) is an enzyme that
uses L-arginine as a substrate, producing the free
radical NO and L-citrulline as coproducts. Three sub-
types of NOS have been described in detail [1,2].
NOS subtypes I, II and III are also commonly
known as neuronal, inducible and endothelial, re-
spectively. Under basal conditions NOS subtypes I
and III produce small amounts of NO. Activation of
receptors leads to either direct or G-protein-mediated
increase in intracellular Ca2. The elevated Ca2 lev-
els activate NOS-I and III, resulting in increased
production of NO. Then, NO activates soluble gua-
nylate cyclase, leading to production of cGMP,
which plays a role in several physiological functions.
In contrast, the transcriptional activation of NOS-II
produces large amounts of NO, independent of Ca2
concentrations. The NO produced by this subtype
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reacts with superoxide to produce peroxynitrite, a
highly cytotoxic molecule. The roles played by NO
are myriad, such as regulation of neurotransmitter
secretion, neurotoxicity, modulation of the immune
response or regulation of blood £ow.
NO is an atypical biomolecule with an ultra-short
half-life and highly di¡usible upon formation [3].
Due to its high reactivity, most of the methods cur-
rently available for detecting the in situ production
of NO in cells are indirect. Some techniques, like in
situ hybridization, allow a semiquantitative measure-
ment of transcriptional changes in NOS mRNAs.
Alternatively, immunocytochemistry allows the de-
termination of the cellular and sub-cellular localiza-
tion of each of the NOS subtypes at the protein level.
In addition, the NADPH-diaphorase histochemical
reaction has been broadly used as a potential marker
of NO-synthesizing enzymes [4,5]. Other direct meth-
ods, such as NO-electrodes, or indirect ones, such as
the Griess or the EPR spin trapping method, are
available to measure NO or NO derivatives such as
nitrites and nitrates that are released in the media.
However, these last methods lack the anatomical res-
olution provided by the previously mentioned ones
(for review, see [6]). A simple and reliable method for
evaluating the in vivo production of NO using the
compound DAF-2 DA has been recently developed
[7]. DAF-2 DA penetrates the cell membrane where
it is hydrolyzed by cytosolic esterases. In the presence
of oxygen, DAF-2 DA or DAF-2 traps NO to pro-
duce a green-£uorescence signal, triazolo£uorescein.
The DAF-2 has low detection limits (2^5 nM) and
broad concentration response range, which allows
semiquantitative analysis.
A diversity of cell types are capable of producing
the di¡erent types of NOS and regulating their ex-
pression in tissues. In particular, NOS-II seems to be
expressed in a variety of cells following induction by
immunologic or in£ammatory stimuli [8,9]. Cell cul-
tures are broadly used as a model to investigate
mechanisms of signal transduction, regulation of
gene expression, cell di¡erentiation and death. There-
fore, given the multiple physiological and patholog-
ical e¡ects of NO in most of the cell functions [8,10],
the intracellular NO levels should be considered as a
potential variable a¡ecting signal-transduction path-
ways. Moreover, the endogenous production of the
free radical in cell lines should facilitate further
mechanistic studies of regulation of NO production.
Thus, the aim of this study was to establish the pres-
ence of NO, and the subtypes of NOS responsible for
its production in commonly used cell lines. Two mur-
ine neuronal cell lines, the neuroblastoma N2A and
the cholinergic SN56, and a transformed monkey
kidney cell line, COS-1, were selected. The basal pro-
duction and the regulation of NO production in
these cell lines was determined using the DAF-2
DA method upon treatment with speci¢c NOS inhib-
itors, NO scavengers, and a NO donor. In addition,
we evaluated the e¡ect of incident light and ¢xation
on the pattern of NO production revealed by the
DAF-2 DA method. The ability to detect NO in
vivo in these cell lines adds a new reference point
for monitoring this particular molecule and its inter-
action with other systems. This will help to provide a
more comprehensive view of the role of NO in cel-
lular signaling.
2. Materials and methods
2.1. Cell culture
COS-1 and N2A cells were obtained from the
American Type Culture Collection (Rockville,
MD), and SN56 cells were a gift from Dr. B. Wainer
(Boston University School of Medicine, MA). Cells
were maintained in Dulbecco’s modi¢ed Eagle’s me-
dium (DMEM) (Life Technologies, Rockville, MD)
devoid of phenol-red and supplemented with 10%
fetal bovine serum (FBS) (Hyclone Labs, Logan,
UT) at 37‡C with 5% CO2. For Western immuno-
blotting studies, the cells were plated on 10-cm tissue
culture dishes at 1U106 cells/dish. For all other ex-
periments, the cells were plated on 8-well slides
(Nunc, Rochester, NY) precoated with polylysine
to yield a density of 3.5U103 cells/well. All cultures
were used 16 h after plating. In one experiment with
SN56 cells, nerve growth factor (NGF) (Life Tech-
nologies) was added to the media at a 10 ng/ml con-
centration the day before processing. For the drug
treatment experiments, cultures were washed in fresh
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DMEM with 10% FBS and incubated for 1 h in the
same media with or without the appropriate concen-
tration of drug.
2.2. 4,5-Diamino£uorescein diacetate (DAF-2 DA)
detection system
For the detection of the NO production, cells were
incubated in 10 WM DAF-2 DA (Calbiochem, San
Diego, CA) for 30 min at 37‡C in a humidi¢ed in-
cubator under an atmosphere with 5% CO2. This
method has been previously described in detail [11].
For drug treatment experiments, cells were ¢rst in-
cubated for 1 h in the DMEM containing the appro-
priate concentration of the drug. We used the
NO scavenger, 2-phenyl-4,4,5,5-tetramethylimidazo-
line-1-oxyl-3-oxide (PTIO), the NOS inhibitors N-
[3-(aminomethyl)benzyl]acetamidine dihydrochloride
(1400W) and Ng-propyl-L-arginine (NPA), all from
Calbiochem, and the NO donor sodium nitroprus-
side from Fisher Scienti¢c (S-350, Fair Lawn, NJ).
Then the medium was discarded and the cells were
incubated in the DAF-2 DA as previously described.
For ¢xation, cells were incubated for 1 h in 0.2%
glutaraldehyde and 4% paraformaldehyde (PA). Al-
ternatively, ¢xation was performed in 2% PA or 4%
PA alone. Control cells were incubated in the same
media without any drug. As negative control, cells
were incubated in media lacking DAF-2 DA. The
cells were then washed in PBS and coverslipped using
Aquamount as the mounting medium.
2.3. NADPH-diaphorase cytochemistry
The NADPH-d method was used as previously
described by Lo¤pez-Figueroa and collaborators [12].
Brie£y, cells were ¢xed in 2% paraformaldehyde (PA)
in PBS for 10 min at room temperature (RT). Cells
were then washed and incubated in a solution con-
taining 1mM L-nicotinamide adenine dinucleotide
phosphate (L-NADPH, Sigma, St. Louis, MO) and
0.1 mM nitro blue tetrazolium (NBT; Sigma) in
phosphate-bu¡ered saline (PBS, pH 7.4) for 1 h at
37‡C. Cells were then washed, dehydrated and cover-
slipped. In order to colocalize NO production with
NADPH-d activity, a subset of the cells were reacted
with DAF-2 DA prior to ¢xation (see below). Con-
trol experiments were performed by omitting L-
NADPH.
2.4. Immunocytochemistry
After ¢xation in 2% PA for 10 min, cells were
washed and incubated in an avidin and biotin block-
ing solution (Vector Labs, Burlingame, CA) for 10
min each, at RT. For NO colocalization, a subset of
the cells was reacted with DAF-2 DA prior to ¢xa-
tion. Following incubation in 1% bovine serum albu-
min (BSA) (Sigma) and 0.3% Triton X-100 for 20
min at RT, cells were further incubated overnight
at 4‡C in the same BSA solution containing the cor-
responding anti NOS-I (diluted 1:3000, Euro-Diag-
nostica, Malmo, Sweden; diluted 1:1000, Transduc-
tion Laboratories, Lexington, KY), anti NOS-II
(diluted 1:2500, A⁄nity Bioreagents, Golden, CO)
and anti NOS-III (diluted 1:2500, Transduction Lab-
oratories) polyclonal antibody. After three 5-min
washes in PBS, cells were incubated in biotin-conju-
gated secondary antibody (diluted 1:1000, Vector
Labs) for 1 h at RT. After washing as above, cells
were incubated in rhodamine-conjugated avidin (di-
luted 1:1000 in PBS, Vector Labs) for 1 h at RT. For
comparison, some cell cultures were developed using
the DAB method as previously described [13]. The
cells were then washed and coverslipped using Aqua-
mount as mounting medium.
2.5. Western blots
Cells were harvested by scraping with a rubber
policeman or trypsinized (0.25% in PBS) in the case
of SN56 cells, and then washed three times with PBS.
Cell pellets were resuspended in 500 Wl of the bu¡er
TEDGM (20 mM sodium molybdate, 20 mM Tris^
HCl, 1 mM EDTA, 5 mM dithiothreitol, 5 Wg/ml
leupeptin, 0.5 mM PMSF, and 10% glycerol, pH
7.6), homogenized at 0‡C by 20 strokes in a Dounce
homogenizer, and centrifuged at 100 000Ug for 1 h
at 2‡C. Aliquots (20 Wg protein) of the resulting cy-
tosolic fractions were electrophoresed in 8% sodium
dodecyl sulfate^polyacrylamide slab gels [14]. For
electroblotting, gels were equilibrated for 1 h at RT
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in a transfer bu¡er consisting of 25 mM Tris, 192
mM glycine and 10% methanol, pH 8.5. Protein
transfer onto Immobilon-P membranes (Millipore
Corp., Bedford, MA) proceeded for 2 h at 200 V
in ice bath. The e⁄ciency of the process was assessed
by the transfer of prestained molecular mass markers
loaded in at least one lane of the gel. Membrane
strips were eventually saved for staining (10 min) in
0.1% Coomassie blue, 10% methanol, and 5% acetic
acid. The entire immunostaining procedure was per-
formed at RT as follows. Blots were ¢rst washed
three times in bu¡er A composed of TBS (20 mM
Tris^HCl, 150 mM NaCl, pH 7.6) and 0.1% Tween
20. Blots were subsequently blocked by incubation
for 1 h in a solution of 10% nonfat dry milk, 0.5%
Tween 20, and TBS. After washing three times in
bu¡er A, blots were incubated for 1 h in a solution
containing the primary rabbit polyclonal antibodies
against NOS-I, -II and -III at a concentration of
1:10 000, 1:4000 and 1:4000, respectively, in bu¡er
B (1% nonfat dry milk, 0.1% Tween 20, TBS). Blots
were extensively washed three times for 15 min in
bu¡er A and incubated for 1 h in a solution contain-
ing a 1:4000 dilution of horseradish peroxidase-
Fig. 1. Identi¢cation of NOS in COS-1 (A,D,G), N2A (B,E,H) and SN56 (C,F) cells. NADPH-diaphorase activity is present in the cy-
tosol and the periphery of the nucleus of COS-1 (A), N2A (B) and SN56 (C). COS-1 (D,G), N2A (E,H) and SN56 (F,I) cells immu-
nostained with a polyclonal antibody against NOS-I (D^F) and NOS-II (G,H). Control immunocytochemistry in the absence of the
primary antibodies (I). Scale bars: A,B,H = 50 Wm; C^F,H,I = 25 Wm; G = 25 Wm.
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coupled second antibody (Amersham Pharmacia Bio-
tech, Piscataway, NJ) in bu¡er B. After extensive
washing as described above, blots were incubated
with the Enhanced Chemi-Luminescence detection
system according to the manufacturer’s instructions
(Amersham Pharmacia Biotech), and emitted light
was detected by direct exposure to Hyper¢lm-ECL
¢lm (Amersham Pharmacia Biotech).
2.6. Image analysis
Images of reacted cells were rapidly digitized with
a Sony DXC-970MD video camera connected to a
Leica DHR epi£uorescence microscope. All of the
images of each experiment were captured under con-
stant exposure time, gain and o¡set. Images were
further analyzed with the MCID image analysis sys-
tem (Imaging, Ontario, Canada). The results are ex-
pressed as relative optical densities (ROD), which
represent the mean optical density minus back-
ground, multiplied by the total target area. Back-
ground was calculated as the mean of all pixels
with lowest optical density outside a cell multiplied
by 3.5 times its standard deviation. Values are the
result of the analysis of at least eight images per
experimental condition, with at least 20 cells per ex-
perimental condition and image. Each condition was
repeated at least three times.
2.7. Statistical analysis
The data are expressed as mean þ S.E.M. Statisti-
cal analysis was made by one-way analysis of var-
iance (ANOVA) followed by post hoc Dunnett’s (vs.
corresponding control) multiple comparison test.
Values of P6 0.05 were considered statistically sig-
ni¢cant.
3. Results
To determine the source of NO production, we
visualized the presence of NOS by NADPH-diaphor-
ase cytochemistry, and by immunocytochemistry us-
ing speci¢c NOS antibodies. We further character-
ized the immunocytochemical ¢ndings by Western
blots. Then, NO production was visualized and char-
acterized using the DAF-2 DA system.
3.1. NADPH-diaphorase
NADPH-d cytochemistry is an indirect method for
detecting NOS activity. We observed positive stain-
ing in all cell lines (Fig. 1A^C). The intensity of the
staining was heterogeneous suggesting di¡erent levels
of activity, as con¢rmed with the DAF-2 DA system
(see below). The subcellular distribution of the
NADPH-d staining was also heterogeneous and in
most cases showed a punctate pattern. Nuclei were
devoid of signal and were usually surrounded by an
intense NADPH-d staining. Star-shaped COS-1 and
SN56 cells presented positive ¢ber-like structures
that were less evident in rounded N2A. All cells pos-
itive for NADPH-d were also positive for DAF-2
(data not shown). No staining was observed in con-
trol cells reacted without L-NADPH.
3.2. Immunocytochemistry
To identify the subtype of NOS responsible for the
observed NO production, immunocytochemistry
(Fig. 1) and Western blots (see below) were per-
formed in cell extracts using speci¢c antibodies
against the three subtypes of NOS. As shown in
Fig. 1D^H, the pattern of NOS I and II subcellular
immunoreactivity was similar to that described above
Fig. 2. Western blot analysis of NOS in COS-1, SN56 and N2A. Lanes: 1,5, positive controls for NOS-I and -II, respectively; 2,6,
COS-1 extracts; 3,7, N2A extracts; 4,8, SN56 extracts. Lanes 1^4 were reacted with anti-NOS-I antibody and lanes 5^8 with NOS-II.
None of the extracts exhibited immunoreactivity towards NOS-III antibody and, for illustration, only the negative result obtained
with COS-1 cells is shown in lane 9. Molecular masses were 160, 130 and 135 kDa for NOS-I, -II and -III, respectively.
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for the NADPH-d staining. Under basal, non-stimu-
lated conditions, COS-1 and N2A cells express NOS-
I and NOS-II, while SN56 cells only express NOSI.
Moreover, no induction of NOS-II was observed ei-
ther after treatment with NGF of SN56 cells for 24 h
(data not shown).
Furthermore, colocalization of NO production
(see below) with the NOS enzyme was assessed by
combining the DAF-2 £uorescence with immuno-
cytochemistry for each NOS subtype. As expected,
all NO producing cells were NOS immunopositive
(data not shown).
No signi¢cant signal was observed when the
immunocytochemistry was performed in the absence
of the primary antibodies (Fig. 1I).
3.3. Western blots
The immunocytochemistry results were con¢rmed
by Western-blot analysis. NOS-I immunoreactivity
was observed in all three of the cell lines as 160
kDa bands (Fig. 2, lanes 2^4). In contrast, NOS-II
immunoreactivity was only observed in COS-1 and
N2A cells as 130 kDa bands (Fig. 2, lanes 6^8), and
no signal was detected in SN56 cells. The 160 and
130 kDa bands were in agreement with values re-
ported for the NOS-I and NOS-II enzymatic sub-
types, respectively. Moreover, similar bands were ob-
tained in samples of brain tissue from rats injected
with interleukin-1L a treatment that induces the ex-
pression of NOS-II [9]. On the other hand, NOS-III
was not detectable in any of the three cell lines (Fig.
2, example of COS-1 cells is shown in lane 9), using a
NOS-III antibody under conditions that detect this
enzyme subtype in a positive lysate control derived
from an aortic endothelium cell line.
3.4. E¡ect of incident light
The intensity of the £uorescent signal increased
proportionally to the amount of time that cells
were stimulated with incident light (Fig. 5). Contin-
uous exposure with epiluminescent light produced a
faster increase in £uorescent signal as compared to
the signal obtained by exposing the cells every 15 s to
short intervals of light. This e¡ect was directly pro-
portional to the magni¢cation power of the objective
utilized for inspection. A U63 magni¢cation objec-
Fig. 3. Photomicrographs illustrating the production of NO in COS-1 cells reacted with DAF-2 DA. Under control conditions, there
is basal NO production (A). Fixation with 4% PA or glutaraldehyde changed the pattern of £uorescence signal compared to cells
without ¢xation (B). Sample images of treatment with 0.1 mM (C,E,G,I) or 1 mM (D,F,H,J) of the appropriate drug. Addition of a
NO donor, SNP, increased the £uorescence intensity in a concentration-dependent manner (C,D). Cells treated with the NOS inhibi-
tors NPA (E,F) or 1400W (G,H) presented reduced intensity of the NO £uorescent signal. The NO scavenger, PTIO, decreased NO
£uorescent signal in a concentration-dependent manner (I,J). Scale bar = 25 Wm.
6
 
Fig. 4. (A) E¡ect of increasing concentrations of the NO scav-
enger, PTIO, and the NOS inhibitors NPA and 1400W on NO
production in COS-1 cells. The results are expressed as relative
optical densities (ROD). (B) Table showing the densitometric
analysis of NO production in COS-1, N2A and SN56 cells by
the DAF-2 method. One-way ANOVA followed by a Dunnett’s
post hoc analysis revealed a signi¢cant reduction of NO pro-
duction with the NO scavenger and the NOS inhibitors com-
pared to control cells. A signi¢cant increase was observed with
the NO donor SNP (*P6 0.05; **P6 0.01; ***P6 0.001).
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tive produced a faster increase in signal compared to
a U40 magni¢cation objective. This increase was not
synchronized in all cells examined, as some cells were
peaking earlier than others, suggesting di¡erences in
metabolic activity. A plateau in £uorescence was
reached as light stimulation continued and was fol-
lowed by decay probably due to quenching.
3.5. Non-treated controls
Following incubation with the DAF-2 DA, we ob-
served green-£uorescent signal in COS-1, SN56 and
N2A cells, that corresponded to basal NO produc-
tion (Fig. 3A).
In general, we observed a heterogeneous distribu-
tion of the green £uorescent signal within, and be-
tween cells. In COS-1 cells, a low signal was observed
that resembled the cytoskeleton. In addition, a more
intense punctated pattern was observed, which was
localized in the cytoplasm of the soma and in di¡er-
entiated ¢ber-like structures. The overall distribution
was similar to that observed with immunocyto-
chemistry of NOS and NADPH-d activity, con¢rm-
ing that NO is the result of the NOS activity. In
contrast, and likely due to NO di¡usion, cell nuclei
were positively stained. The pattern of £uorescence
intensity observed among SN56 and N2A cells was
also heterogeneous, probably re£ecting the di¡eren-
tial metabolic stages of the cells. Because of the
round shape and relatively large nuclear size, the
subcellular pattern of DAF-2 £uorescence in these
cell lines was less striking than in COS-1 cells. The
£uorescence signal was almost undetectable in con-
trol cells incubated without DAF-2 DA.
3.6. NO donor
Incubation of cells with the NO donor SNP (0.1
and 1 mM) induced a signi¢cant increase in £uores-
cent intensity (Figs. 3C,D and 4B). The e¡ect was
most signi¢cant at a concentration of 1 mM.
3.7. NOS inhibitors
Incubation of COS-1 cells with increasing concen-
trations (0.1, 0.5, 1 and 2 mM) of the NOS inhibitors
1400W (Fig. 3E,F) and NPA (Fig. 3G,H) resulted in
a concentration-dependent decrease in £uorescent in-
tensity (Fig. 4A). Both inhibitors produced their
maximum e¡ect at a concentration of 2 mM. Based
on these results, we selected two subsaturating doses
(0.1 and 1 mM) to compare the response of the other
cell lines to the NOS inhibitors and observed the
same dose-dependent inhibitory e¡ect (Fig. 4B).
Fig. 5. Graph showing the time course of the intensity of the £uorescent signal of cells exposed to constant incident light (open), and
under intermittent exposure with digitization every 20 seconds (close). In the same graph we show the e¡ect of using a high (63U)
and a lower (40U) power objective. Data are expressed as the mean ROD þ S.E.M.
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3.8. NO scavenger
To assess that the £uorescence signal was the re-
sult of NO production, we incubated the COS-1 cells
in media containing increasing concentrations the
NO scavenger PTIO (0.1, 0.5, 1 and 2 mM). Similar
to e¡ects of the NOS inhibitors, the £uorescence sig-
nal decreased in a dose-dependent manner with
PTIO (Figs. 3I,J and 4A). At 1 mM PTIO the £uo-
rescence signal was signi¢cantly reduced. The same
pattern of results was observed in N2A and SN56
cells (Fig. 4B).
3.9. E¡ect of ¢xation
We studied the e¡ect of ¢xation in cells reacted
with DAF-2. We observed that a ¢xative containing
a mixture of 0.2% glutaraldehyde and 4% paraform-
aldehyde (PA) abolished the DAF-2 £uorescence sig-
nal. Fixation with 4% PA produced a punctate £uo-
rescence pattern (Fig. 3B), while 2% PA eliminated
most of the signal in the periphery, leaving £uores-
cence in the center of the cell. Control cells reacted
with DAF-2 that underwent no ¢xation presented a
characteristic pattern of the £uorescent signal. Fixa-
tion abolished the changes in £uorescence signal ob-
served in un¢xed cells.
4. Discussion
In the present study, we show the in situ produc-
tion and subcellular distribution of NO in three com-
monly used cell lines: N2A, SN56 and COS-1. The
¢rst two were chosen because of their neuronal char-
acteristics [15,16], whereas COS-1 was used as a com-
parable non-neuronal cell line. First, the presence of
the NO-synthesizing enzyme was indirectly con-
¢rmed by cytochemistry using the NADPH-diaphor-
ase method. Second, we demonstrated the presence
of NOS subtypes I and II in two of these cell lines,
COS-1 and N2A, and the NOS subtype I in SN56
cells by immunocytochemistry and Western blots.
Finally, we validated the DAF-2 method to study
the in vivo cellular distribution and regulation of
NO production, using NO donors and NOS-speci¢c
inhibitors to con¢rm that the £uorescent signal re-
£ects NO levels. We also showed that the DAF-£uo-
rescence signal is a¡ected by the conditions of cell
¢xation and of incident light.
The NADPH-diaphoretic activity was ¢rst used as
a potential marker of NOS in COS-1, SN56 and
N2A cells. Our results are consistent with those pre-
viously observed in N2A cells [17] ; however, this is
the ¢rst report of the presence of NADPH-diapho-
retic activity in COS-1 and SN56 cells. Because
NADPH-d is also a marker for other diaphoretic
enzymes, such as the cytochrome P450, we used spe-
ci¢c antibodies to determine the presence and sub-
types of NOS. Our immunocytochemistry and West-
ern blot results are consistent with the presence of
NOS subtypes I and II in N2A and COS-1 cells, and
only subtype I in SN56 cells. Interestingly, although
the presence of NOS-I in N2A cells has been previ-
ously reported [17], the authors did not observe the
NOS-II isoform in their study. Presently, we have no
explanation for this discrepancy other than di¡erent
culture conditions or di¡erentiation stages of the cul-
tured cells.
The expression of the inducible isoform of NOS
(NOS-II) under non-stimulated conditions in COS-1
and N2A cells represents a novel and unexpected
¢nding. Although NOS-II has been described in
many cell types, its expression always followed in-
duction by immunologic or in£ammatory stimuli
(see [8] for a review), or by growth factors in the
case of early stages of di¡erentiating neurons (see
[18] for a review). In our hands, the neuronal and
the kidney cell lines, both expressed NOS-II when
maintained under standard culture conditions in reg-
ular media supplemented with 10% FCS and without
any further treatment.
The expression of a NOS protein was previously
described in SN56 cells [19]. However, the subtype
characterization was not possible because the anti-
body used recognizes a protein region common to
all the isoforms [20,21]. Thus, to our knowledge,
this is the ¢rst clear demonstration of expression of
the neuronal isoform (NOS-I) in the cholinergic
model. Nevertheless, we did not observe NOS-II ex-
pression in SN56 cells under standard culture condi-
tions and these neurons lacked NOS-II induction
even after treatment with NGF, a growth factor
that leads PC12 cells to di¡erentiation and NOS-II
expression [22].
The present paper provides further evidence for
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the utility of the DAF-2 system for the semiquanti-
tative analysis and visualization of the subcellular
production of NO in living cells. Although the spe-
ci¢city and detection limits of the DAF-2 system
have been a subject of discussion, Kojima and col-
laborators [7] have demonstrated that the DAF-2
DA is a highly speci¢c probe that does not recognize
other reactive species such as Oc2, H2O2, NO
3
2 and
NO33 . Besides, the low detection limits of DAF-2 (2^
5 nM) make it an ideal method for detecting basal
NO production in living cells. Thus, the combination
of speci¢city and low detection limit of the DAF-2
DA technique o¡ers great advantage when compared
to other methods such as spin trapping or electrodes,
that do not provide the subcellular anatomical reso-
lution.
In our cell lines NO production was observed as a
dispersed or punctate £uorescent signal in the cyto-
plasm. We have recently demonstrated that part of
the punctate signal observed in COS-1 and PC12
cells is produced within mitochondria, a key meta-
bolic organelle [23]. A similar £uorescent pattern has
also been reported in brain slices [24]. Moreover, our
results utilizing NOS modulators substantiate that
the DAF-2 method re£ects the enzymatic production
of NO in vivo. Thus, while in the presence of NOS
inhibitors or of a NO scavenger we observed that
DAF-2 £uorescence signal decreased in a dose-de-
pendent manner, the addition of a NO donor caused
an increase in the £uorescence signal. Nevertheless,
our stimulation/inhibition results were comparable in
all the cell types studied, con¢rming and giving fur-
ther evidence of the presence and regulation of di¡er-
ent subtypes of NOS.
It is worthy to note that although the £uorescence
intensity was increased in a concentration-dependent
manner concomitantly with the amount of NO in
our in vivo experiments, ¢xation a¡ects the intensity
and distribution of the DAF-2 £uorescent signal. We
showed that strong ¢xation considerably reduce the
NO £uorescent signal, resulting in an artifactual and
punctate pattern, whereas under mild ¢xation only
NO £uorescent signal in the periphery of cells is
lost. This susceptibility to ¢xation seems to be in
agreement with previous observations on the di¡er-
ential e¡ect of ¢xation on NOS detection by immu-
nohistochemistry and histochemistry, and NO detec-
tion by the DAF-2 method [25,26]. Other signi¢cant
factors a¡ecting the £uoresce emission are the speci-
men illumination time and intensity, as recently re-
ported by Broillet and collaborators [27]. We ob-
served that, upon a variable and relatively short lag
phase, emission increased gradually, reaching plateau
values after 1^2 min and ¢nally decaying. However,
optimal conditions of constant exposure time and
microscopic magni¢cation allowed us to compare
the e¡ect of NO donors, inhibitors and scavengers
in a semi-quantitative way. Broillet and collaborators
also found that the NO detection by DAF-2 is en-
hanced by the presence of divalent cations, an im-
portant factor to be considered especially because of
the changing Ca2 concentration within the cell.
Although cellular Ca2 levels were not controlled
in this report, it is suggestive that a series of treat-
ments modulating NO at di¡erent levels mostly
changed signal intensity, not distribution. Thus,
under the described experimental conditions, our
measurements would indicate changes in NO, rather
than Ca2, levels. As we previously discussed [11],
the use of the DAF-2 DA method in living cells
requires very careful planning of the experimental
conditions but it could be used as a semi-quantitative
method to compare cells exposure to di¡erent treat-
ments.
It is important to note that the cell lines used in
this work have been used in a variety of studies with-
out considering the possibility of endogenous pro-
duction of NO. For example, transfection studies
have been used as an in vivo model of gene expres-
sion and regulation [28^30]. More speci¢cally, COS-1
and N2A cells have been used to express novel NOS
clones [31^34] or to demonstrate the interaction with
intracellular pathways such as cGMP activation [15].
Therefore, our ¢nding of basal expression of NOS
subtypes and NO production has a direct impact
on studies using the cell lines herein described.
In conclusion, the present study demonstrates the
presence of NOS protein and activity as well as the
regulation of NO production in COS-1, SN56 and
N2A cells. In particular, we provide cytological evi-
dence for the subcellular distribution of NO and its
synthesizing enzyme. Given the multiple physiologi-
cal and pathological e¡ects of NO in cell signal
transduction pathways, our data is relevant for the
interpretation of results of previous and future stud-
ies utilizing these cell lines.
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